The March Fund
Overview
The March Fund is a venture capital firm investing in technology, food, and health sectors. The March Group is backing exponential technology platforms for human & planetary health, and a new food paradigm. The March Fund is an early/late stage investment capital fund in food, beverage and retail technologies committed to creating and scaling new, profitable companies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| EvodiaBio | Jun 2024 | Series A | Lead |
| Number 8 Bio | Sep 2024 | Seed | Co-investor |
| Amplifye | Jul 2024 | Series A | Co-investor |
| Engage3 | Dec 2021 | Series D | Co-investor |
For institutional investors. Book with your work email.
Key People
Tom Andriola
Venture Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is The March Fund based?
The March Fund is headquartered in Davis, California, United States.
When was The March Fund founded?
The March Fund was founded in 2018.
How many portfolio companies does The March Fund have?
The March Fund has 5 portfolio companies in Caplight's dataset.
What are some companies in The March Fund's portfolio?
Portfolio companies visible on Caplight include EvodiaBio, Number 8 Bio, Amplifye, Engage3.
What was The March Fund's most recent investment shown here?
The March Fund's most recent investment in this portfolio sample was in Number 8 Bio in 2024.
What sectors does The March Fund focus on?
The March Fund focuses on Healthcare & Life Sciences, Consumer & Commerce, Healthcare & Life Sciences, Consumer & Commerce, Energy & Sustainability, Healthcare & Life Sciences, Enterprise Software, Frontier & Industrial Tech, Consumer & Commerce, Energy & Sustainability.
What company stages does The March Fund focus on?
Stage focus information for The March Fund is not publicly available.
What is The March Fund's AUM?
The March Fund's assets under management are estimated between $0.0 and $50.0M.